Browsing Centre for Endocrinology by Title
Now showing items 21-40 of 560
-
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients.
(2022-10-01)OBJECTIVE: To describe clinical and pathological characteristics and treatment outcomes in a large cohort of aggressive pituitary tumours (APT)/pituitary carcinomas (PC). DESIGN: Electronic survey August 2020-May 2021. ... -
AIP and the somatostatin system in pituitary tumours
(2017-12-01)© 2017 Society for Endocrinology Printed in Great Britain. Classic somatostatin analogues aimed at somatostatin receptor type 2, such as octreotide and lanreotide, represent the mainstay of medical treatment for acromegaly. ... -
AIP and the somatostatin system in pituitary tumours.
(2017-12)Classic somatostatin analogues aimed at somatostatin receptor type 2, such as octreotide and lanreotide, represent the mainstay of medical treatment for acromegaly. These agents have the potential to decrease hormone ... -
AIP mutations in brazilian patients with sporadic pituitary adenomas: A single-center evaluation
(2017-11-01)© 2017 The authors Published by Bioscientifica Ltd. Aryl hydrocarbon receptor-interacting protein (AIP) gene mutations (AIPmut) are the most frequent germline mutations found in apparently sporadic pituitary adenomas (SPA). ... -
AIPvariant causing familial prolactinoma
(2020-10-03) -
An analysis of surveillance screening for SDHB-related disease in childhood and adolescence.
(2019-03-01)Objective Phaeochromocytomas (PCC) and paragangliomas (PGL) are rare in children. A large proportion of these are now understood to be due to underlying germline mutations. Here we focus on succinate dehydrogenase subunit ... -
Assessment of Cardiavascular Changes following Trans-sphenoidal Surgery in Acromegalic Patients.
(Medknow Publications, 2019-09-10)Cardiovascular disease represents the most prevalent comorbidity in acromegaly, accounting for up to 80% of complications and it has been reported to importantly contribute to death.[1] In this issue of Neurology India, ... -
Association of Self-Reported Polycystic Ovary Syndrome, Obesity, and Weight Gain From Adolescence to Adulthood With Hypertensive Disorders of Pregnancy: A Community-Based Approach.
(2021-02-01)The purpose of this prospective, population-based cohort study was to evaluate the roles of polycystic ovary syndrome (PCOS), obesity, weight gain, and hyperandrogenemia in the development of hypertensive disorders of ...